Progressive Care, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
November 14, 2023 at 06:29 am EST
Share
Progressive Care, Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was USD 9.86 million compared to USD 8.95 million a year ago. Net loss was USD 1.37 million compared to USD 9.5 million a year ago. Basic loss per share from continuing operations was USD 0.22 compared to USD 3.29 a year ago. Diluted loss per share from continuing operations was USD 0.22 compared to USD 3.29 a year ago.
For the nine months, sales was USD 19.19 million compared to USD 27.75 million a year ago. Net loss was USD 4.77 million compared to USD 11.75 million a year ago.
Progressive Care, Inc. is a personalized healthcare services and technology provider. The Company operates through two segments: Pharmacy Operations and Third-Party Administration. The Pharmacy Operations segment provides prescription pharmaceuticals, compounded medications, tele-pharmacy services, COVID-19 related diagnostics and vaccinations, anti-retroviral medications, medication therapy management, the supply of prescription medications to long-term care facilities, medication adherence packaging, and contracted pharmacy services for 340B covered entities under the 340B Drug Discount Pricing Program. The Third-Party Administration segment provides data management and reporting services to support health care organizations. It offers services in a variety of languages, including English, Spanish, French, Creole, Portuguese, Ukrainian and Russian. Through its wholly owned subsidiary, ClearMetrX, it offers data management and reporting services to support health care organizations.